entertainment -WSS

entertainment

author：fashion 2025-09-02 22:07:33 - browse：51

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Medicare isn't yet testing food as medicine

WSS

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Virtual repurposing can help discover new uses for existing drugs

Listen: Vivek Ramaswamy's star turn & leaky drug data

Doctor of U.S. President Joe Biden says he is fit for duty

How the drug

Using force crossed my mind when examining a defiant young patient

Wikipedia

entertainment

explore

How one medical school became remarkably diverse

Health officials lay out plans to cope with respiratory virus season

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Color Health wants to make cancer screenings convenient

Moonlake's readout produced a cash windfall. Risks remain

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Supreme Court strikes down use of affirmative action

Abortion policy in the spotlight at Republican debate

Medical leaders decry Supreme Court decision on affirmative action

People can get long Covid without testing positive for virus: Study

knowledge

How the drug

National associations that represent hospice owe an apology

FDA greenlights medical device to combat bladder issues

Pfizer is about to make a big push in cancer. Will investors listen?

Are embryos people? Reproductive medicine's future depends on the answer

Are embryos people? Reproductive medicine's future depends on the answer

explore

focus

explore

knowledge